Alpha-interferon administration in cytomegalovirus retinitis

Four patients, including three with the acquired immunodeficiency syndrome (AIDS), were treated with high-dose, buffy coat-derived alpha-interferon for progressive cytomegalovirus retinitis. Two of these patients had decreased viruria during therapy and the other two had increased viruria. There was evidence of progression of disease despite therapy in all patients, although the retinitis eventually became quiescent in the patient without AIDS. The severe immunosuppression encountered in AIDS patients complicates the management of cytomegalovirus and other opportunistic infections.

[1]  T. Merigan,et al.  Rapid detection and quantitation of human cytomegalovirus in urine through DNA hybridization. , 1983, The New England journal of medicine.

[2]  J. Connor,et al.  Treatment of cytomegalovirus pneumonia with high-dose acyclovir. , 1982, The American journal of medicine.

[3]  B. Bean,et al.  Acyclovir in immunocompromised patients with cytomegalovirus disease. A controlled trial at one institution. , 1982, The American journal of medicine.

[4]  K. Cantell,et al.  Treatment of cytomegalovirus pneumonia after marrow transplant with combined vidarabine and human leukocyte interferon. , 1982, The Journal of infectious diseases.

[5]  R. Yee,et al.  Ocular disorders associated with a new severe acquired cellular immunodeficiency syndrome. , 1982, American journal of ophthalmology.

[6]  M. Hirsch,et al.  Virus-specific IgG and IgM antibodies in normal and immunocompromised subjects infected with cytomegalovirus. , 1982, The Journal of infectious diseases.

[7]  T. Merigan,et al.  Cytomegalovirus retinitis in immunosuppressed hosts. I. Natural history and effects of treatment with adenine arabinoside. , 1980, Annals of internal medicine.

[8]  T. Merigan,et al.  Cytomegalovirus retinitis in immunosuppressed hosts. II. Ocular manifestations. , 1980, Annals of internal medicine.

[9]  H. Balfour,et al.  A trial of vidarabine for cytomegalovirus infection in renal transplant patients. , 1980, Archives of internal medicine.

[10]  P. Neiman,et al.  Toxicity and efficacy of human leukocyte interferon for treatment of cytomegalovirus pneumonia after marrow transplantation. , 1980, The Journal of infectious diseases.

[11]  T. Merigan,et al.  Effect of leukocyte interferon on urinary excretion of cytomegalovirus by infants. , 1976, The Journal of infectious diseases.

[12]  T. Merigan,et al.  Physical properties of human interferon prepared in vitro and in vivo. , 1966, Virology.